CT-stereotactic fibrinolysis of spontaneous intracerebral hematomas.
CT-stereotactic fibrinolysis is an effective alternative to surgical and conservative therapies for intracerebral hematoma. The method consists of stereotactically puncturing and partially evacuating the hematoma. After fibrinolysis using urokinase, the residual hematoma is completely evacuated through a catheter inserted in the cavity of the hematoma. The operation is usually performed under local anesthesia. Stereotactic methods are safer and less invasive than other methods. Since October 1985, a total of 85 patients have been treated with this method in the Department of Stereotaxy and Neuronuclear Medicine at the University of Freiburg Medical School. Although 25 patients died (29.4%) during the mean follow-up period of 20 months, only 16 (18.8%) died in the acute postoperative phase or within the first 60 days after evacuation. Eighteen patients (21.2%) had died six months after the operation. The quality of life of the 60 surviving patients, as measured on the Karnofsky Scale at follow-up, was very good to good in 70% and moderate in 23.3%. Only 6.7% of the patients were so disabled that they required special care and assistance or had to be placed in a nursing home. The long-term results are thus very encouraging.
Mohadjer
M
M
Department of Neurosurgery, University of Freiburg Medical School, Fed. Rep. of Germany.
Braus
D F
DF
Myers
A
A
Scheremet
R
R
Krauss
J K
JK
D002423:Cause of Death; D002543:Cerebral Hemorrhage / Q000188:drug therapy* / Q000401:mortality; D004322:Drainage / Q000295:instrumentation*; D005500:Follow-Up Studies; D015600:Glasgow Coma Scale; D006801:Humans; D015552:Injections, Intralesional; D013238:Stereotaxic Techniques / Q000295:instrumentation*; D015912:Thrombolytic Therapy / Q000295:instrumentation*; D014057:Tomography, X-Ray Computed / Q000295:instrumentation*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D014568:Urokinase-Type Plasminogen Activator